Oral treatment with valacyclovir for HSV-2-associated eczema herpeticum in a 9-month-old infant: A case report
Kaiwen Zhuang1, Qiong Wu, Xin Ran
1Department of Dermatovenereology, West China Hospital, Sichuan University Department of Diagnostic Ultrasound, Second University Hospital of Sichuan University Department of Lab Medicine Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Background:
Eczema herpeticum is a rare, severe, and disseminated infection of herpes simplex virus in the setting of eczematous skin diseases.
Methods:
We experienced a case of this disease in a 9-month-old infant characterized by a sudden onset of monomorphic vesicles on the head, right lower leg, and two hands. The infant has a 7-month history of atopic dermatitis and his condition was initially regarded as a complication of atopic dermatitis and bacterial infection. After treatment of cefoperazone and dexamethasone, the eruptions got worse. The diagnosis of eczema herpeticum was made according to the clinical features and further confirmed by the findings of herpes simplex virus type 2.
Results:
The infant was cured by oral treatment with valacyclovir.
Conclusion:
The case highlights that the awareness for the sign of eczema herpeticum when diagnosing children with a sudden onset of disseminated vesicles in the setting of chronic skin disease should be increased. Oral valacyclovir may be an effective and convenient treatment option for pediatric outpatients with eczema herpeticum.
